Literature DB >> 24690035

MLK3 as a regulator of disease progression in Non-alcoholic steatohepatitis.

Joy X Jiang1, Natalie J Török.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24690035      PMCID: PMC4392882          DOI: 10.1111/liv.12556

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  27 in total

1.  Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways.

Authors:  Nyaya Kelkar; Claire L Standen; Roger J Davis
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.

Authors:  Rajat Singh; Yongjun Wang; Youqing Xiang; Kathryn E Tanaka; William A Gaarde; Mark J Czaja
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

3.  Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3.

Authors:  N Kelkar; S Gupta; M Dickens; R J Davis
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  Who pulls the trigger: JNK activation in liver lipotoxicity?

Authors:  Samar H Ibrahim; Gregory J Gores
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

5.  Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.

Authors:  Harmeet Malhi; Steven F Bronk; Nathan W Werneburg; Gregory J Gores
Journal:  J Biol Chem       Date:  2006-02-27       Impact factor: 5.157

6.  Role of the mixed-lineage protein kinase pathway in the metabolic stress response to obesity.

Authors:  Shashi Kant; Tamera Barrett; Anastassiia Vertii; Yun Hee Noh; Dae Young Jung; Jason K Kim; Roger J Davis
Journal:  Cell Rep       Date:  2013-08-15       Impact factor: 9.423

7.  Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3.

Authors:  I W Leung; N Lassam
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

Review 8.  Mixed-lineage kinase control of JNK and p38 MAPK pathways.

Authors:  Kathleen A Gallo; Gary L Johnson
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

9.  Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.

Authors:  Puneet Puri; Faridoddin Mirshahi; Onpan Cheung; Ramesh Natarajan; James W Maher; John M Kellum; Arun J Sanyal
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

10.  NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

Authors:  Geoffrey C Farrell; Derrick van Rooyen; Lay Gan; Shivrakumar Chitturi
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

View more
  4 in total

Review 1.  Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis.

Authors:  Alexander Wree; Wajahat Z Mehal; Ariel E Feldstein
Journal:  Semin Liver Dis       Date:  2016-02-12       Impact factor: 6.115

Review 2.  Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications.

Authors:  Chen Wang; Jinwen Liu; Yongmin Yan; Youwen Tan
Journal:  J Immunol Res       Date:  2022-05-06       Impact factor: 4.493

3.  Loss of TRB3 alters dynamics of MLK3-JNK signaling and inhibits cytokine-activated pancreatic beta cell death.

Authors:  Rohan K Humphrey; Anamika Ray; Sumati Gonuguntla; Ergeng Hao; Ulupi S Jhala
Journal:  J Biol Chem       Date:  2014-09-09       Impact factor: 5.157

Review 4.  Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease.

Authors:  Robert W M Min; Filbert W M Aung; Bryant Liu; Aliza Arya; Sanda Win
Journal:  Biomedicines       Date:  2022-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.